Israel’s Arkin Holdings launches second biotech fund, worth $140 million
Four years after launching their first biotech fund, Arkin Holdings is scaling up.
The Israeli investment firm is teaming with Phoenix Group on a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
